Login

ARQULE INC 3 SEC Filings

Filed On Filing
16 Dec 2019 Form 3: Merck & Co., Inc., 10% owner and 1 other

Holds 0 shares of Common Stock, par value $0.01

09 Apr 2019 Form 3: Schamber Blaine, VP, Finance, CAO

Holds 31,967 shares of Common Stock

09 Apr 2019 Form 3: Schegerin Marc, SVP and CFO
20 Nov 2017 Form 3: Nussbaum Ran, Director

No securities owned

20 Oct 2017 Form 3: Bvf Partners L P/IL, 10% owner and 6 others

Holds 7,704,831 shares of Common Stock, $0.01 par value per share

05 May 2011 Form 3: Kelley Susan L., Director

No securities owned

25 Nov 2008 Form 3: Chan Thomas C K, Chief Scientific Officer
16 Jul 2008 Form 3: Schwartz Brian, Chief Medical Officer

No securities owned

11 Jun 2008 Form 3: Pucci Paolo, Chief Executive Officer

No securities owned

11 Jan 2008 Form 3: Bvf Partners L P/IL, 10% owner and 4 others

Holds 1,433,077 shares of Common Stock

23 Jul 2007 Form 3: Weiskopf Robert J, VP Finance & Corp Controller

Holds 4,000 shares of Common Stock

18 Jan 2007 Form 3: Loberg Michael D, Director

No securities owned

05 Sep 2006 Form 3: Woodrich Richard H, Acting Chief Financial Officer

Holds 100 shares of Common Stock

03 Aug 2006 Form 3: Rulewski Nigel J, Chief Medical Officer

No securities owned

15 May 2006 Form 3: Simonian Nancy A, Director

No securities owned

17 Apr 2006 Form 3: Lawrence Peter S, Gen Counsel/Chief Business Off

No securities owned

13 Jun 2005 Form 3: Lindsay Ronald M, Director

No securities owned

11 Apr 2005 Form 3: Astrue Michael J, Director

No securities owned

20 Jan 2005 Form 3: Messenger William G, Director

Holds 700 shares of Common Stock

19 Dec 2003 Form 3: Mawhinney Louise, VP Finance, Treasurer and CFO

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support